Analyst firms · Wedbush · VRNS

Wedbush VRNS price target and rating history

Varonis Systems Inc. (VRNS) · Technology

Wedbush rates Varonis Systems Inc. (VRNS) Neutral with a $46 price target, as of its latest action on Sep 11, 2026. It has published 5 rating actions on VRNS since August 2021, including 1 upgrade and 2 downgrades. Across 8 firms with a VRNS price target in the last 12 months, the median target is $45.50. Wedbush's $46 is 1% above that.

Current rating

Neutral

Price target

$46

Median target, all firms

$45.50

Actions on VRNS

5

Wedbush price target on VRNS

Every Wedbush rating on VRNS

• Sep 11, 2026
  DowngradeWedbush downgrades to Neutral from Outperform, price target $46
• Feb 6, 2024
  UpgradeWedbush upgrades to Outperform from Neutral, price target $35 to $65
• Nov 1, 2022
  DowngradeWedbush downgrades to Neutral from Outperform, price target $40 to $20
• Feb 8, 2022
  ReiterateWedbush cuts its price target to $60 from $80, keeps Outperform
• Aug 3, 2021
  ReiterateWedbush raises its price target to $80 from $70, keeps Outperform

How other firms rate VRNS

Each firm's latest rating and stated target in the last 12 months.

Questions about Wedbush and VRNS

What is Wedbush's price target for VRNS?

Wedbush's latest stated price target for Varonis Systems Inc. (VRNS) is $46, from its action on Sep 11, 2026.

What is Wedbush's rating on VRNS?

Wedbush rates VRNS Neutral, a neutral rating, as of Sep 11, 2026.

When did Wedbush last change its view on VRNS?

On Sep 11, 2026, Wedbush downgrades to Neutral from Outperform, price target $46.

How does Wedbush's VRNS target compare with other analysts?

Across 8 firms with a VRNS price target in the last 12 months, the median target is $45.50. Wedbush's $46 is 1% above that.

More VRNS rating histories

• Stephens4
• Barclays3
• Wells Fargo6
• DA Davidson3
• Morgan Stanley4
• Jefferies3
• Wolfe Research3
• Robert W. Baird3
• J.P. Morgan3

All Wedbush ratingsVRNS news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.